It sounds like you're asking whether anyone has had long enough experience with Amaatig (efgartigimod alfa-fcab) to share results!
There is some clinical trial data available. In a randomized, double-blind trial involving adults with generalized MG, participants treated with efgartigimod alfa-fcab showed meaningful Show Full Answer
It sounds like you're asking whether anyone has had long enough experience with Amaatig (efgartigimod alfa-fcab) to share results!
There is some clinical trial data available. In a randomized, double-blind trial involving adults with generalized MG, participants treated with efgartigimod alfa-fcab showed meaningful improvements after just four weeks.
Key findings included:
- An average 3.35-point improvement in MG Activities of Daily Living (MG-ADL) scores
- Improvements were seen across multiple treatment cycles
- The MG-ADL scale measures things like speech, chewing, swallowing, breathing, vision, and arm and leg strength
The safety profile was consistent with earlier studies, with no new safety concerns identified.
That said, individual results can vary quite a bit. It's always worth having an open conversation with your neurologist about what kind of improvement timeline is realistic for your specific situation.
AI-generated responses are not a substitute for medical advice. These services are not intended to
diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.
FDA Expands Vyvgart Approval to All Adults With gMG
June 23
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
